Details
Stereochemistry | RACEMIC |
Molecular Formula | C18H19N3O |
Molecular Weight | 293.363 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1C2=C(C3=C1C=CC=C3)C(=O)C(CN4C=CN=C4C)CC2
InChI
InChIKey=FELGMEQIXOGIFQ-UHFFFAOYSA-N
InChI=1S/C18H19N3O/c1-12-19-9-10-21(12)11-13-7-8-16-17(18(13)22)14-5-3-4-6-15(14)20(16)2/h3-6,9-10,13H,7-8,11H2,1-2H3
Molecular Formula | C18H19N3O |
Molecular Weight | 293.363 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 19:13:09 UTC 2023
by
admin
on
Fri Dec 15 19:13:09 UTC 2023
|
Record UNII |
4AF302ESOS
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ESSENTIAL MEDICINES LIST |
17.2
Created by
admin on Fri Dec 15 19:13:09 UTC 2023 , Edited by admin on Fri Dec 15 19:13:09 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
8.4
Created by
admin on Fri Dec 15 19:13:09 UTC 2023 , Edited by admin on Fri Dec 15 19:13:09 UTC 2023
|
||
|
LIVERTOX |
711
Created by
admin on Fri Dec 15 19:13:09 UTC 2023 , Edited by admin on Fri Dec 15 19:13:09 UTC 2023
|
||
|
NCI_THESAURUS |
C267
Created by
admin on Fri Dec 15 19:13:09 UTC 2023 , Edited by admin on Fri Dec 15 19:13:09 UTC 2023
|
||
|
NDF-RT |
N0000175818
Created by
admin on Fri Dec 15 19:13:09 UTC 2023 , Edited by admin on Fri Dec 15 19:13:09 UTC 2023
|
||
|
NDF-RT |
N0000175817
Created by
admin on Fri Dec 15 19:13:09 UTC 2023 , Edited by admin on Fri Dec 15 19:13:09 UTC 2023
|
||
|
WHO-VATC |
QA04AA01
Created by
admin on Fri Dec 15 19:13:09 UTC 2023 , Edited by admin on Fri Dec 15 19:13:09 UTC 2023
|
||
|
WHO-ATC |
A04AA01
Created by
admin on Fri Dec 15 19:13:09 UTC 2023 , Edited by admin on Fri Dec 15 19:13:09 UTC 2023
|
||
|
NCI_THESAURUS |
C94726
Created by
admin on Fri Dec 15 19:13:09 UTC 2023 , Edited by admin on Fri Dec 15 19:13:09 UTC 2023
|
||
|
FDA ORPHAN DRUG |
491115
Created by
admin on Fri Dec 15 19:13:09 UTC 2023 , Edited by admin on Fri Dec 15 19:13:09 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
4AF302ESOS
Created by
admin on Fri Dec 15 19:13:09 UTC 2023 , Edited by admin on Fri Dec 15 19:13:09 UTC 2023
|
PRIMARY | |||
|
D017294
Created by
admin on Fri Dec 15 19:13:09 UTC 2023 , Edited by admin on Fri Dec 15 19:13:09 UTC 2023
|
PRIMARY | |||
|
757870
Created by
admin on Fri Dec 15 19:13:09 UTC 2023 , Edited by admin on Fri Dec 15 19:13:09 UTC 2023
|
PRIMARY | |||
|
1992
Created by
admin on Fri Dec 15 19:13:09 UTC 2023 , Edited by admin on Fri Dec 15 19:13:09 UTC 2023
|
PRIMARY | |||
|
8304
Created by
admin on Fri Dec 15 19:13:09 UTC 2023 , Edited by admin on Fri Dec 15 19:13:09 UTC 2023
|
PRIMARY | |||
|
m8213
Created by
admin on Fri Dec 15 19:13:09 UTC 2023 , Edited by admin on Fri Dec 15 19:13:09 UTC 2023
|
PRIMARY | Merck Index | ||
|
Ondansetron
Created by
admin on Fri Dec 15 19:13:09 UTC 2023 , Edited by admin on Fri Dec 15 19:13:09 UTC 2023
|
PRIMARY | |||
|
5965
Created by
admin on Fri Dec 15 19:13:09 UTC 2023 , Edited by admin on Fri Dec 15 19:13:09 UTC 2023
|
PRIMARY | |||
|
ONDANSETRON
Created by
admin on Fri Dec 15 19:13:09 UTC 2023 , Edited by admin on Fri Dec 15 19:13:09 UTC 2023
|
PRIMARY | |||
|
SUB09445MIG
Created by
admin on Fri Dec 15 19:13:09 UTC 2023 , Edited by admin on Fri Dec 15 19:13:09 UTC 2023
|
PRIMARY | |||
|
26225
Created by
admin on Fri Dec 15 19:13:09 UTC 2023 , Edited by admin on Fri Dec 15 19:13:09 UTC 2023
|
PRIMARY | RxNorm | ||
|
1478571
Created by
admin on Fri Dec 15 19:13:09 UTC 2023 , Edited by admin on Fri Dec 15 19:13:09 UTC 2023
|
PRIMARY | |||
|
99614-02-5
Created by
admin on Fri Dec 15 19:13:09 UTC 2023 , Edited by admin on Fri Dec 15 19:13:09 UTC 2023
|
SUPERSEDED | |||
|
4595
Created by
admin on Fri Dec 15 19:13:09 UTC 2023 , Edited by admin on Fri Dec 15 19:13:09 UTC 2023
|
PRIMARY | |||
|
2290
Created by
admin on Fri Dec 15 19:13:09 UTC 2023 , Edited by admin on Fri Dec 15 19:13:09 UTC 2023
|
PRIMARY | |||
|
DTXSID8023393
Created by
admin on Fri Dec 15 19:13:09 UTC 2023 , Edited by admin on Fri Dec 15 19:13:09 UTC 2023
|
PRIMARY | |||
|
CHEMBL46
Created by
admin on Fri Dec 15 19:13:09 UTC 2023 , Edited by admin on Fri Dec 15 19:13:09 UTC 2023
|
PRIMARY | |||
|
C1119
Created by
admin on Fri Dec 15 19:13:09 UTC 2023 , Edited by admin on Fri Dec 15 19:13:09 UTC 2023
|
PRIMARY | |||
|
DB00904
Created by
admin on Fri Dec 15 19:13:09 UTC 2023 , Edited by admin on Fri Dec 15 19:13:09 UTC 2023
|
PRIMARY | |||
|
4AF302ESOS
Created by
admin on Fri Dec 15 19:13:09 UTC 2023 , Edited by admin on Fri Dec 15 19:13:09 UTC 2023
|
PRIMARY | |||
|
99614-02-5
Created by
admin on Fri Dec 15 19:13:09 UTC 2023 , Edited by admin on Fri Dec 15 19:13:09 UTC 2023
|
PRIMARY | |||
|
100000092334
Created by
admin on Fri Dec 15 19:13:09 UTC 2023 , Edited by admin on Fri Dec 15 19:13:09 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
USP
|
||
|
METABOLIC ENZYME -> INHIBITOR |
IC50
|
||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
TARGET -> INHIBITOR |
IC50
|
||
|
BINDER->LIGAND |
BINDING
|
||
|
TRANSPORTER -> SUBSTRATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE INACTIVE -> PARENT | |||
|
METABOLITE -> PARENT | |||
|
METABOLITE ACTIVE -> PARENT |
Multiple P450 isoforms; Not found in plasma at concentrations likely to significantly contribute to the biological activity of ondansetron
|
||
|
METABOLITE -> PARENT |
multiple CYP isoforms
|
||
|
METABOLITE -> PARENT |
Multiple CYP isoforms
|
||
|
METABOLITE -> PARENT |
Multiple CYP isoenzymes
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
Children <15 Years PHARMACOKINETIC |
|
||